SYNTHESIS OF THE PHARMACEUTICAL ASPIRIN (ACETYLSALICYLIC ACID) AIM: The aim for this experiment was to synthesise a small amount of aspirin with salicylic acid as the starting product and sulphuric acid as the catalyst. The product obtained from this reaction will be impure and will need to be purified. This will be done by recrystallization. We will then record the products’ melting point and calculate the yield in order to determine the degree of purity of the aspirin sample. Diagrammatic scheme
Premium Acetic acid Aspirin Acetic anhydride
The burden of the responsible falls onto to ZAP Pharmaceutical Company since both contact: Written and oral are bindings. According to Section 2-209 of the Uniform Commercial Code it seeks to protect and make effective all necessary and desirable modifications of sales contracts without regards to the technicalities which[at common law] hamper such adjustment. Subsection (1) permits all modifications‚ written and oral‚ to be binding without consideration. Subsection (2) allows the parties to exclude
Premium Law Contract Contractual term
The global pharmaceutical industry 1. Identify the main environmental forces currently affecting the global pharmaceutical industry. The PESTEL analysis can be used to identify the main environmental forces for the industry: Political • Stringent government regulation and powerful purchaser pressures. • Governments around the world focused on pharmaceuticals as a politically easy target in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic
Premium Pharmaceutical industry Generic drug Food and Drug Administration
ASSIGNMENT PHARMACEUTICAL INDUSTRY SUBMITTED TO: PROF. JEEMOL UNNI SUBMITTED BY: PUNEET JAIN (33101) Market Failure The involvement of government in the pharmaceutical sector has been to a much greater extent when compared to other sectors. We have studied that in the scenario of “Perfect Markets” where consumers and sellers are left to their own to carry out business activities lead to an optimal solution. However it’s a bit different in case of pharmaceutical sector‚ because if pharmaceutical companies
Premium Pharmacology Pharmaceutical industry Clinical trial
Risinger David.Risinger@morganstanley.com +1 (1)212 761 6494 Thomas Chiu Thomas.Chiu@morganstanley.com +1 (1)212 761 3688 Dana Yi Industry View In-Line October 18‚ 2010 Dana.Yi@morganstanley.com +1 (1)212 761 8713 Large Cap & Specialty Pharmaceuticals Christopher Caponetti Christopher.Caponetti@morganstanley.com +1 (1)212 761 6235 Pharma trends in pictures In this note‚ we include macro trend analysis plus therapeutic category and product-specific charts. Macro pages to start; then company
Premium Morgan Stanley
API PRESENTATTION Some Definitions- Active Pharmaceutical Ingredient (API): A substance or compound that is intended to be used in the manufacture of a pharmaceutical product as a therapeutically active compound (ingredient) Enantiomers: cpds with same molecular formula as substance but differ in spatial arrangement of atoms and are non-superimpossable mirror images Polymorphism: Occurrence of different crystalline forms of the same substance Degradation product : Molecule resulting
Premium Pharmacology Chemistry Pharmaceutical drug
|The Pharmaceutical Industry | |Consolidated Paper | | | Table of Contents Introduction 3 Macro-Environmental Challenges 3 Political Challenges within the Macro-Environment 5 Economic Challenges within the Macro-Environment 8 Social Challenges within the Macro-Environment 11 Technological
Premium Pharmaceutical industry Pharmacology Generic drug
III – Which are the largest city economies in the world and how might this change by 2025? This article updates an article published in our March 2007 UK Economic Outlook1 giving estimates for 2005 and projections to 2020 of the size of the largest 100 city economies in the world. The updated analysis and illustrative projections of GDP for different cities show how the GDP rankings of cities might change by 2025 taking into account the impact of the current economic downturn and the
Premium Developed country Economic growth Gross domestic product
Quality Assurance‚ Lorex Pharmaceuticals From: Ed Melton‚ Consultant‚ Cougar Consulting CC: Prof. Laura Swanson‚ Managing Consultant/Professor‚ Cougar Consulting Date: 2/12/15 Re: Linatol Fill Rate Analysis and Recommendation Summary On August 19th‚ 2014‚ Lorex Pharmaceutical requested assistance from Cougar Consulting to help determine the optimal fill rate for their new product Linatol‚ a cutting edge treatment for patients with high blood pressure. Lorex Pharmaceutical provided Cougar Consulting
Premium Variable cost Costs Contribution margin
Government Account securities. Most of this is owed to Social Security and other trust funds‚ which were running surpluses. These securities are a promise to repay these funds when Baby Boomers retire over the next 20 years. The U.S. debt is the largest in the world. How did it get so large? Purchasers of Treasury bills still reasonably expect the U.S. economy to recover enough to pay them back. For foreign investors like China
Premium United States United States public debt United Kingdom